Inmunómica traslacional en neoplasias hematológicas
Pfizer (United States)
Nueva York, Estados UnidosPfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2024
-
Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study
HemaSphere
-
Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing
Clinical and Translational Oncology
2023
-
Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning
Thrombosis Research, Vol. 228, pp. 181-188